Is photobiomodulation therapy effective in reducing pain caused by toxicities related to head and neck cancer treatment? A systematic review
- 1 July 2019
- journal article
- review article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 27 (11) , 4043-4054
Abstract
Photobiomodulation therapy (PBMT) has been considered an effective method for preventing and managing certain cancer-related toxicities in head and neck cancer (HNC) patients treated with radiotherapy and chemotherapy. However, the potential effects of PBMT on pain control and analgesia resulting from these toxicities is still controversial. The aim of this systematic review was to compile available evidence of the effects of PMBT on pain control and reduced use of analgesics in HNC patients. We searched three indexed databases: MEDLINE/PubMed, Embase, and Scopus. The databases were reviewed up to and including December 2018. Only human clinical studies in English language were selected. Information was only available for mucositis and radiodermatitis. Fifteen out of 1112 studies met the inclusion criteria (14 for oral mucositis (OM) and 1 for radiodermatitis). From the 14 studies involving the prevention and treatment of OM, 10 had the study subjects compared to a placebo group. Of these 10 studies, all but 1 showed statistically significant difference related to pain control favoring the PBMT group. The study that compared PBMT with other treatment modality showed better results in pain control with PBMT. It appears that PBMT application frequency and potency impact on pain control. The only study involving the prevention and treatment of radiodermatitis was compared to placebo arm and showed statistically significant difference related to pain control favoring the PBMT group. Seven studies compared the need of analgesic medication between PBMT and placebo groups. Of these, five studies showed that the use of analgesic medication was significantly higher in the placebo group. The current evidence supports that PBMT is effective in pain control resulting from OM and radiodermatitis and may also reduce the need for analgesics. The evidence is not yet available of the effects of PBMT in other HNC treatment-related toxicities.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2018/02233-6, 2013/18402-8, 2012/06138-1)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 50 references indexed in Scilit:
- Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study GroupSupportive Care in Cancer, 2013
- A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositisSupportive Care in Cancer, 2011
- Use of 660-nm Diode Laser in the Prevention and Treatment of Human Oral Mucositis Induced by Radiotherapy and ChemotherapyPhotomedicine and Laser Surgery, 2010
- Laser phototherapy as topical prophylaxis against head and neck cancer radiotherapy‐induced oral mucositis: Comparison between low and high/low power lasersLasers in Surgery and Medicine, 2009
- Molecular mechanisms of cell proliferation induced by low power laser irradiationJournal of Biomedical Science, 2009
- In vitro effects of low‐level laser irradiation for bone marrow mesenchymal stem cells: Proliferation, growth factors secretion and myogenic differentiationLasers in Surgery and Medicine, 2008
- Analgesic Effect of He-Ne (632.8 nm) Low-Level Laser Therapy on Acute Inflammatory PainPhotomedicine and Laser Surgery, 2005
- Increased fibroblast proliferation induced by light emitting diode and low power laser irradiationLasers in Medical Science, 2003
- Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignanciesOral Oncology, 2000
- Low-energy He/Ne laser in the prevention of radiation-induced mucositisSupportive Care in Cancer, 1999